1. Yi JM, Kim TO. Epigenetic alterations in inflammatory bowel disease and cancer. Intest Res. 2015; 13:112–121. PMID:
25931995.
Article
2. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013; 368:407–415. PMID:
23323867.
Article
3. Colman RJ, Rubin DT. Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis. 2014; 8:1569–1581. PMID:
25223604.
Article
4. Moayyedi P, Surette MG, Kim PT, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015; 149:102–109.e6. PMID:
25857665.
Article
5. Rossen NG, Fuentes S, van der Spek MJ, et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology. 2015; 149:110–118.e4. PMID:
25836986.
Article
6. Paramsothy S, Kamm MA, Kaakoush NO, et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet. 2017; 389:1218–1228. PMID:
28214091.
Article
7. Ng WK, Wong SH, Ng SC. Changing epidemiological trends of inflammatory bowel disease in Asia. Intest Res. 2016; 14:111–119. PMID:
27175111.
Article
8. Mizuno S, Nanki K, Matsuoka K, et al. Single fecal microbiota transplantation failed to change intestinal microbiota and had limited effectiveness against ulcerative colitis in Japanese patients. Intest Res. 2017; 15:68–74. PMID:
28239315.
Article
9. Bak SH, Choi HH, Lee J, et al. Fecal microbiota transplantation for refractory Crohn's disease. Intest Res. 2017; 15:244–248.
Article